What Is Vitamin K1 (Phylloquinone)?
Vitamin K1, or phylloquinone, is the primary dietary form of vitamin K — a fat-soluble vitamin essential for blood coagulation and increasingly recognized for its roles in bone metabolism and cardiovascular health. The name "vitamin K" derives from the German word Koagulationsvitamin, reflecting its discovery in the context of blood clotting research in the 1930s.
Vitamin K exists in two main natural forms: K1 (phylloquinone), found predominantly in green leafy vegetables and plant foods, and K2 (menaquinone), found in fermented foods and animal products. While both forms activate vitamin K-dependent proteins, they differ significantly in their tissue distribution, half-life, and biological effects — making them complementary rather than interchangeable.
K1 is the dominant form in the human diet and is preferentially taken up by the liver, where it is used to activate clotting factors. K2, by contrast, has a longer half-life and is more efficiently distributed to extrahepatic tissues including bone and arterial walls. Understanding this distinction is critical for both dietary planning and supplementation strategy.
Primary Functions of Vitamin K1
Blood Coagulation
Vitamin K1's most well-characterized role is as an essential cofactor for the enzyme gamma-glutamyl carboxylase, which activates a family of proteins known as vitamin K-dependent proteins (VKDPs). In the coagulation cascade, K1 activates clotting factors II (prothrombin), VII, IX, and X, as well as the anticoagulant proteins C and S. Without adequate vitamin K1, these factors cannot be carboxylated and activated, leading to impaired clot formation and bleeding risk.
This is the mechanism by which warfarin (Coumadin) works — it antagonizes vitamin K recycling, reducing the activity of K-dependent clotting factors. Patients on warfarin must carefully monitor their vitamin K1 intake to maintain stable anticoagulation.
Bone Metabolism
Vitamin K activates osteocalcin — a protein produced by osteoblasts (bone-building cells) that is required for the incorporation of calcium into the bone matrix. Undercarboxylated osteocalcin cannot bind calcium effectively, impairing bone mineralization. Both K1 and K2 contribute to osteocalcin activation, though K2 (particularly MK-7) appears to be more potent for bone-specific effects due to its longer half-life and greater extrahepatic distribution.
Epidemiological studies consistently associate higher vitamin K1 intake with greater bone mineral density and reduced fracture risk, particularly in older adults and postmenopausal women.
Cardiovascular Protection
Vitamin K activates Matrix Gla Protein (MGP) — the most potent known inhibitor of vascular calcification. MGP prevents calcium from depositing in arterial walls, maintaining arterial flexibility and reducing cardiovascular risk. While K2 (especially MK-7) is more effective at activating MGP in arterial tissue due to its superior extrahepatic bioavailability, K1 also contributes to MGP activation and cardiovascular protection at adequate dietary intakes.
Anti-Inflammatory Effects
Emerging research suggests vitamin K has anti-inflammatory properties independent of its carboxylation functions. Higher vitamin K status has been associated with lower levels of inflammatory markers including IL-6 and CRP, and with reduced risk of inflammatory conditions. The mechanisms are not fully elucidated but may involve modulation of NF-κB signaling pathways.
Vitamin K1 vs. Vitamin K2: Key Differences
| Feature | Vitamin K1 (Phylloquinone) | Vitamin K2 (Menaquinone) |
|---|---|---|
| Primary sources | Green leafy vegetables, plant oils | Fermented foods, animal products, gut bacteria |
| Half-life | Short (hours) | Long (days, especially MK-7) |
| Primary tissue | Liver (clotting factors) | Bone, arteries, extrahepatic tissues |
| Blood clotting | Primary role | Secondary role |
| Bone health | Moderate effect | Superior effect (especially MK-7) |
| Arterial calcification | Moderate effect | Superior effect |
| Dietary abundance | High (leafy greens) | Lower (natto, aged cheese, organ meats) |
The two forms are best viewed as complementary: K1 ensures adequate hepatic clotting factor activation, while K2 provides superior protection for bone and vascular tissues. Optimal vitamin K status ideally includes adequate intake of both forms.
Deficiency: Symptoms & Risk Factors
Deficiency Symptoms
- Easy bruising
- Prolonged bleeding from cuts or wounds
- Heavy menstrual bleeding
- Blood in urine or stool
- Nosebleeds
- Reduced bone mineral density and increased fracture risk
- In newborns: vitamin K deficiency bleeding (VKDB) — a potentially life-threatening condition
Risk Factors for Deficiency
- Low intake of green leafy vegetables
- Fat malabsorption syndromes (Crohn's disease, celiac disease, short bowel syndrome, cystic fibrosis)
- Chronic antibiotic use (disrupts gut bacteria that produce menaquinones)
- Warfarin and other vitamin K antagonist medications
- Cholestyramine and other bile acid sequestrants (impair fat-soluble vitamin absorption)
- Newborns (low placental transfer, low breast milk content — reason for routine K1 injection at birth)
- Liver disease (impairs vitamin K utilization)
- Long-term total parenteral nutrition without K supplementation
Food Sources
Vitamin K1 is found almost exclusively in plant foods, particularly green vegetables:
- Richest sources: Kale, collard greens, spinach, Swiss chard, turnip greens, mustard greens
- Other vegetables: Broccoli, Brussels sprouts, cabbage, asparagus, green onions
- Herbs: Parsley, basil, sage, thyme
- Plant oils: Soybean oil, canola oil, olive oil
- Legumes: Soybeans, edamame
Important: Vitamin K1 is fat-soluble — absorption is significantly enhanced when consumed with dietary fat. Adding olive oil, avocado, or nuts to leafy green salads substantially increases K1 bioavailability.
Recommended Daily Allowance (RDA)
No RDA has been established for vitamin K. An Adequate Intake (AI) is used:
- Adult men (19+): 120 mcg/day
- Adult women (19+): 90 mcg/day
- Pregnant women: 90 mcg/day
- Breastfeeding women: 90 mcg/day
These AIs are based primarily on preventing deficiency-related bleeding. Optimal intakes for bone and cardiovascular protection may be higher, and many integrative practitioners recommend ensuring both K1 and K2 are adequate rather than relying on K1 alone.
Supplement Forms & Considerations
- Phylloquinone (K1): The standard supplemental form; effective for clotting support and general vitamin K status.
- Combined K1 + K2 formulas: Increasingly recommended to address both hepatic (clotting) and extrahepatic (bone, vascular) needs simultaneously.
- Warfarin interaction: Patients on warfarin must not supplement vitamin K1 without medical supervision, as it directly antagonizes the drug's mechanism. Consistent (not variable) K1 intake is key to stable INR management.
Therapeutic Applications
- Osteoporosis prevention: Vitamin K supplementation (K1 and/or K2) has demonstrated reductions in fracture risk and improvements in bone mineral density, particularly in postmenopausal women.
- Vascular calcification: Combined K1 + K2 supplementation is used in integrative cardiology to reduce arterial calcification progression.
- Newborn VKDB prevention: Intramuscular K1 injection at birth is standard of care to prevent vitamin K deficiency bleeding in neonates.
- Warfarin management: Low-dose K1 supplementation (100–200 mcg/day) can stabilize INR variability in warfarin patients with inconsistent dietary K intake — under medical supervision.
- Liver disease: Vitamin K supplementation may partially correct coagulopathy in patients with impaired hepatic vitamin K utilization.
Safety & Toxicity
Vitamin K1 (phylloquinone) has no established tolerable upper intake level (UL) and is considered very safe at supplemental doses. No adverse effects from high oral intake have been documented in healthy individuals. The primary safety consideration is its interaction with anticoagulant medications — particularly warfarin — which requires careful management. Synthetic vitamin K3 (menadione) is toxic at high doses, but this form is not used in human supplementation.
Key Takeaways
- Vitamin K1 (Phylloquinone) is the primary dietary form of vitamin K, found abundantly in green leafy vegetables.
- It is essential for blood coagulation, activating clotting factors II, VII, IX, and X in the liver.
- K1 also contributes to bone mineralization and vascular calcification prevention, though K2 is superior for extrahepatic tissue effects.
- Absorption is fat-dependent — always consume K1-rich foods with dietary fat.
- Patients on warfarin must manage K1 intake carefully and consult their physician before supplementing.
- Optimal vitamin K status for bone and cardiovascular health ideally includes both K1 and K2.
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before beginning any supplementation protocol.
0 comments